Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any primary pulmonary hypertension in which the cause of the disease is a mutation in the SMAD9 gene.
Features include always present findings: Increased pulmonary vascular resistance; and common findings: High blood pressure in lung arteries (pulmonary arterial hypertension) and Abnormally loud pulmonic component of the second heart sound.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 2 | High blood pressure in lung arteries (pulmonary arterial hypertension), Abnormally loud pulmonic component of the second heart sound |
SMAD9 function has not been fully characterized.
Pulmonary hypertension, primary, 2 is associated with mutations in the SMAD9 gene on chromosome 13.
Genetic testing for SMAD9 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for pulmonary hypertension, primary, 2 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 2 common features.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
275 publications have been identified in PubMed for pulmonary hypertension, primary, 2. Kisho has analyzed 169 by research type. Research spans Epidemiology / Natural History (25%), Clinical Trial Publication (24%), and Basic Science / Preclinical (19%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 43 |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 6:36 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Lungs and breathing | 2 | High blood pressure in lung arteries (pulmonary arterial hypertension), Increased pulmonary vascular resistance |
Clinical study results | 41 | 24% |
Laboratory research | 32 | 19% |
Research summaries | 31 | 18% |
Testing and diagnosis research | 16 | 9% |
Patient case studies | 3 | 2% |
New treatment approaches | 3 | 2% |
Chen H (2026). [PMID: 41412527](https://pubmed.ncbi.nlm.nih.gov/41412527/). *Free Radic Biol Med*. [Basic Science / Preclinical]
Zarrabian B (2026). [PMID: 41412359](https://pubmed.ncbi.nlm.nih.gov/41412359/). *J Heart Lung Transplant*. [Clinical Trial Publication]
Shaukat M (2026). [PMID: 41611798](https://pubmed.ncbi.nlm.nih.gov/41611798/). *Sci Rep*. [Basic Science / Preclinical]
Zhang W (2026). [PMID: 41213438](https://pubmed.ncbi.nlm.nih.gov/41213438/). *Free Radic Biol Med*. [Basic Science / Preclinical]
Reddy VY (2026). [PMID: 41563170](https://pubmed.ncbi.nlm.nih.gov/41563170/). *J Am Coll Cardiol*. [Clinical Trial Publication]
Reddy YNV (2026). [PMID: 41885673](https://pubmed.ncbi.nlm.nih.gov/41885673/). *J Am Coll Cardiol*. [Clinical Trial Publication]
Reddy YNV (2026). [PMID: 41685452](https://pubmed.ncbi.nlm.nih.gov/41685452/). *Circulation*. [Epidemiology / Natural History]
Jambon-Barbara C (2026). [PMID: 41674449](https://pubmed.ncbi.nlm.nih.gov/41674449/). *Circulation*. [Epidemiology / Natural History]
Chen HM (2026). [PMID: 41493267](https://pubmed.ncbi.nlm.nih.gov/41493267/). *JACC Cardiovasc Imaging*. [Diagnostic / Biomarker]
Zheng S (2026). [PMID: 41922023](https://pubmed.ncbi.nlm.nih.gov/41922023/). *BMJ Open Respir Res*. [Epidemiology / Natural History]